Abdul Mannan: Venous Thromboembolism Prophylaxis Is Often Overlooked in Medical Inpatients
Abdul Mannan, Consultant Haematologist at Betsi Cadwaladr University Health Board, posted on LinkedIn:
”Venous thromboembolism remains a leading cause of preventable hospital deaths, yet prophylaxis is often overlooked in medical inpatients. Evidence shows that systematic risk assessment using tools like the Padua Score, combined with bleeding-risk stratification (IMPROVE), saves lives. Pharmacological prophylaxis with LMWH reduces VTE by up to 50% in at-risk patients, whilst mechanical methods offer alternatives when bleeding risk is high. As clinicians, we must embed VTE assessment into daily practice—document decisions, reassess regularly, and champion mechanical prophylaxis when pharmacological options are contraindicated. Let’s ensure every patient receives the right prophylaxis at the right time. Prevention is always better than treatment.”
Learn more here.
Stay updated on all scientific advances with Hemostasis Today.
-
Dec 18, 2025, 17:13Daria Camilli on EuroBloodNet and EHC Collaboration for Bleeding Disorders
-
Dec 18, 2025, 16:50Marie Cambot on Innovhem’s Quantification of The HbF/HbS Ratio for SCD
-
Dec 18, 2025, 16:26Yogesh Rathod on Hematological Issues and ICU
-
Dec 18, 2025, 16:09Carlos Doti: I’m Reminded Why ASH is Such a Powerful Close to The Year
-
Dec 18, 2025, 15:23Michael Hadley: Well-Timed ACC Statement Just Out in JACC Journals
-
Dec 18, 2025, 15:12Wolfgang Miesbach on Insights from Guy Young’s ASH2025 Session on Next-Generation Gene Therapy
-
Dec 18, 2025, 14:15Plasma-Derived Therapy for Hemophilia in The Updated European Medicines Agency’s Union List
-
Dec 18, 2025, 13:55Laurent Bertoletti: BAT-VTE is One of 7 Projects Funded Under the EFFECT Trial Call!
-
Dec 18, 2025, 13:34Alexandru Stieber Explores VEXAS Syndrome